Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds EF Hutton Maintains Buy on Electromed, Raises Price Target to $15

EF Hutton Maintains Buy on Electromed, Raises Price Target to $15

EF Hutton analyst Constantine Davides maintains Electromed (AMEX:ELMD) with a Buy and raises the price target from $13.5 to $15.

byBenzinga Newsdesk

February 16, 2023

1 minute read

EF Hutton analyst Constantine Davides maintains Electromed (AMEX:ELMD) with a Buy and raises the price target from $13.5 to $15.

Analyst Ratings

Analyst Ratings for Evolent Health

By Benzinga Insights

June 26, 4:01 PM

Analysts have provided the following ratings for Evolent Health (NYSE:EVH) within the last quarter: Bullish Somewhat Bullish Indifferent…

EVH

Analyst Ratings

Expert Ratings for DraftKings

By Benzinga Insights

October 16, 8:01 AM

Within the last quarter, DraftKings (NASDAQ:DKNG) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

DKNG

Analyst Ratings

DA Davidson Maintains Buy Rating for Waldencast: Here’s What You Need To Know

By Benzinga Insights

November 17, 1:00 PM

DA Davidson has decided to maintain its Buy rating of Waldencast (NASDAQ:WALD) and raise its price target from…

WALD

Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday

By Lisa Levin

July 28, 10:46 AM

U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose 53.3% to $166.41 after Biogen agreed to acquire the company.

BFST

EF Hutton Maintains Buy on Electromed, Raises Price Target to $15

Related Posts

Analyst Ratings for Evolent Health

Expert Ratings for DraftKings

DA Davidson Maintains Buy Rating for Waldencast: Here’s What You Need To Know

Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday